Ligand Pharmaceuticals Incorporated (LGND)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 11,942 | 3,037 | 103,851 | 37,500 | 807,076 |
| Revenue | US$ in thousands | 133,379 | 199,338 | 288,204 | 176,413 | 85,278 |
| Operating profit margin | 8.95% | 1.52% | 36.03% | 21.26% | 946.41% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $11,942K ÷ $133,379K
= 8.95%
Ligand Pharmaceuticals, Inc.'s operating profit margin has shown variability over the past five years. In 2023, the company's operating profit margin stood at 7.48%, a significant improvement from the previous year where it was 1.55%. This suggests that the company was able to generate more profit from its core operations in 2023.
In contrast, the operating profit margin was notably higher in 2021 at 28.47%, indicating strong operational efficiency and profitability during that period. However, there was a decline in 2022 to 1.55%, which may have been a cause for concern.
The operating profit margin in 2020 was 4.68%, showing a moderate increase from the negative margin of -2.36% in 2019. Overall, the trend in the company's operating profit margin fluctuated significantly over the past five years, signaling potential fluctuations in operational efficiency and profitability. Further analysis of the company's cost structure and revenue generation may provide insights into the factors driving these fluctuations.
Peer comparison
Dec 31, 2023